Hebbar M - Search Results

1

Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature.

Hebbar M, Kozlowski D, Wattel E, Mastrini S, Diévart M, Duclos B, Bonaz B, d'Almagne H, Belaiche J, Colombel JF, Fenaux P. Hebbar M, et al. Leukemia. 1997 Dec;11(12):2188-91. doi: 10.1038/sj.leu.2400863. Leukemia. 1997. PMID: 9447839 Review.

2

The role of intensive chemotherapy in myelodysplastic syndromes.

Fenaux P, Preudhomme C, Hebbar M. Fenaux P, et al. Among authors: hebbar m. Leuk Lymphoma. 1992 Sep;8(1-2):43-9. doi: 10.3109/10428199209049816. Leuk Lymphoma. 1992. PMID: 1493470 Review.

3

Association of myelodysplastic syndrome and relapsing polychondritis: further evidence.

Hebbar M, Brouillard M, Wattel E, Decoulx M, Hatron PY, Devulder B, Fenaux P. Hebbar M, et al. Leukemia. 1995 Apr;9(4):731-3. Leukemia. 1995. PMID: 7723411 Review.

4

De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?

Wattel E, Laï JL, Hebbar M, Preudhomme C, Grahek D, Morel P, Bauters F, Fenaux P. Wattel E, et al. Among authors: hebbar m. Leuk Res. 1993 Nov;17(11):921-6. doi: 10.1016/0145-2126(93)90038-m. Leuk Res. 1993. PMID: 8231232 Review.

5

Long-term survivors in myelodysplastic syndromes: a report on 63 cases and comparison with short and intermediate survivors.

Wattel E, Hecquet B, Grahek D, Hebbar M, Morel P, Lai JL, Bauters F, Fenaux P. Wattel E, et al. Among authors: hebbar m. Leuk Res. 1993 Sep;17(9):733-9. doi: 10.1016/0145-2126(93)90106-u. Leuk Res. 1993. PMID: 8371573

6

Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.

Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P. Morel P, et al. Among authors: hebbar m. Leukemia. 1993 Sep;7(9):1315-23. Leukemia. 1993. PMID: 8371581

7

[Systemic diseases in myelodysplastic syndromes].

Hebbar M, Hebbar-Savéan K, Fenaux P. Hebbar M, et al. Among authors: hebbar savean k. Rev Med Interne. 1995;16(12):897-904. doi: 10.1016/0248-8663(96)80810-1. Rev Med Interne. 1995. PMID: 8570952 Review. French.

8

Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens.

Preudhomme C, Nisse C, Hebbar M, Vanrumbeke M, Brizard A, Lai JL, Fenaux P. Preudhomme C, et al. Among authors: hebbar m. Leukemia. 1997 Sep;11(9):1580-2. doi: 10.1038/sj.leu.2400767. Leukemia. 1997. PMID: 9305616

9

Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.

Hebbar M, Kaplan C, Caulier MT, Wattel E, Morel P, Wetterwald M, Bauters F, Fenaux P. Hebbar M, et al. Br J Haematol. 1996 Jul;94(1):112-5. doi: 10.1046/j.1365-2141.1996.6322262.x. Br J Haematol. 1996. PMID: 8757517

10

Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques.

Morel P, Declercq C, Hebbar M, Bauters F, Fenaux P. Morel P, et al. Among authors: hebbar m. Br J Haematol. 1996 Jul;94(1):116-9. doi: 10.1046/j.1365-2141.1996.6122056.x. Br J Haematol. 1996. PMID: 8757518

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters